About Gujarat Themis Biosyn
Gujarat Themis Biosyn is a company based in Vapi (India) founded in 1981. The company has 372 employees as of March 31, 2024. Gujarat Themis Biosyn offers products and services including Rifampicin. Gujarat Themis Biosyn operates in a competitive market with competitors including Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
- Headquarter Vapi, India
- Employees 372 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Gujarat Themis Biosyn Ltd
-
Annual Revenue
$17.67 M (USD)-11.2as on Mar 31, 2025
-
Net Profit
$5.71 M (USD)-17.56as on Mar 31, 2025
-
EBITDA
$8.3 M (USD)-9.97as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
372
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Gujarat Themis Biosyn
Gujarat Themis Biosyn is a publicly listed company on the NSE with ticker symbol GUJTHEM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Gujarat Themis Biosyn
Gujarat Themis Biosyn offers a comprehensive portfolio of products and services, including Rifampicin.
Antibiotic for tuberculosis treatment manufactured commercially.
Funding Insights of Gujarat Themis Biosyn
Detailed funding history for Gujarat Themis Biosyn
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gujarat Themis Biosyn
Investment portfolio details for Gujarat Themis Biosyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gujarat Themis Biosyn
Detailed financials for Gujarat Themis Biosyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gujarat Themis Biosyn Comparisons
Peer comparison for Gujarat Themis Biosyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gujarat Themis Biosyn
Gujarat Themis Biosyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Gujarat Themis Biosyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gujarat Themis Biosyn
Complete news archive for Gujarat Themis Biosyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gujarat Themis Biosyn
Gujarat Themis Biosyn was founded in 1981.
Gujarat Themis Biosyn is headquartered in Vapi, India. It is registered at Vapi, Gujarat, India.
Tapas Bhudebendranath Guhathakurata is the current CEO of Gujarat Themis Biosyn.
As of Mar 31, 2024, the latest employee count at Gujarat Themis Biosyn is 372.
Annual revenue of Gujarat Themis Biosyn is $17.67M as on Mar 31, 2025.
Gujarat Themis Biosyn was established in 1981 and is headquartered in Vapi, India. Operations are centered on the information technology sector, where application development services are delivered to support software needs. The company functions within the software services industry, focusing on custom application solutions. Leadership is provided by CEO Tapas Bhudebendranath Guhathakurata, with activities conducted primarily in the Indian market.
Gujarat Themis Biosyn's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Gujarat Themis Biosyn offers Rifampicin.
Yes, Gujarat Themis Biosyn is publicly traded on NSE under the ticker symbol GUJTHEM.
The ticker symbol of Gujarat Themis Biosyn is GUJTHEM on NSE.